Get the Stockscreener App
4.32
0.46%
-0.02
Clarivate Plc stock is traded at $4.32, with a volume of 3.65M.
It is down -0.46% in the last 24 hours and up +3.60% over the past month.
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.
See More
Previous Close:
$4.34
Open:
$4.4
24h Volume:
3.65M
Relative Volume:
0.62
Market Cap:
$2.88B
Revenue:
$2.58B
Net Income/Loss:
$-1.29B
P/E Ratio:
-2.1818
EPS:
-1.98
Net Cash Flow:
$425.40M
1W Performance:
+2.37%
1M Performance:
+3.60%
6M Performance:
-24.48%
1Y Performance:
-25.00%
1-Day Range:
$4.30
$4.43
1-Week Range:
$4.055
$4.445
52-Week Range:
$3.04
$7.15
Clarivate Plc Stock (CLVT) Company Profile
Name
Clarivate Plc
Sector
Industry
Phone
(207) 433-4000
Address
4TH FLOOR, ST. PAUL'S GATE, ST. HELIER
Compare CLVT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLVT
Clarivate Plc
|
4.32 | 2.88B | 2.58B | -1.29B | 425.40M | -1.98 |
|
IBM
International Business Machines Corp
|
268.87 | 240.77B | 62.83B | 5.47B | 11.94B | 5.81 |
|
ACN
Accenture Plc
|
317.65 | 198.34B | 67.22B | 7.68B | 9.75B | 12.11 |
|
FI
Fiserv Inc
|
166.71 | 90.26B | 20.70B | 3.25B | 4.96B | 5.66 |
|
INFY
Infosys Ltd Adr
|
18.20 | 75.39B | 19.28B | 3.16B | 2.53B | 0.76 |
|
FIS
Fidelity National Information Services Inc
|
81.23 | 41.83B | 10.19B | 825.00M | 1.58B | 1.52 |
Clarivate Plc Stock (CLVT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-15-23 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Oct-16-23 | Upgrade | Jefferies | Hold → Buy |
| Sep-08-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-25-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Aug-07-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-04-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jun-13-23 | Initiated | Oppenheimer | Outperform |
| Mar-15-23 | Resumed | BofA Securities | Neutral |
| Feb-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-13-22 | Initiated | Wells Fargo | Overweight |
| Feb-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-03-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-21-21 | Resumed | Citigroup | Buy |
| Dec-13-21 | Resumed | Goldman | Buy |
| Aug-16-21 | Initiated | BofA Securities | Buy |
| Aug-04-21 | Resumed | RBC Capital Mkts | Outperform |
| Mar-31-21 | Initiated | Jefferies | Buy |
| Mar-11-21 | Resumed | Citigroup | Buy |
| Mar-08-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Clarivate Plc Stock (CLVT) Latest News
Clarivate (CLVT) Partners with Canadian Research Consortium | CL - GuruFocus
Clarivate Partners with CRKN to Further Canada's Research Goals - GuruFocus
Clarivate (CLVT) Partners with Canadian Research Consortium | CLVT Stock News - GuruFocus
Clarivate enters multi-year pact with Canadian Research Knowledge Network - TipRanks
Clarivate Partners with Canadian Research Knowledge Network to Further Canada's Research Goals - marketscreener.com
Clarivate Renews Partnership Deal With Network of Canadian Institutions - marketscreener.com
Clarivate Partners with CRKN to Further Canada's Research Goals | CLVT Stock News - GuruFocus
Clarivate Partners With CRKN To Further Canada's Research Goals - Barchart.com
Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil - The Malaysian Reserve
Clarivate renews multi-year partnership with CAPES - TipRanks
Clarivate Upsizes Term Loan to Refinance 2026 Notes - marketscreener.com
Is There An Opportunity With Clarivate Plc's (NYSE:CLVT) 26% Undervaluation? - Yahoo Finance
Clarivate Completes Refinancing of Majority of Senior Secured Notes Due 2026 - marketscreener.com
Clarivate Secures $500M Term Loans in May 2025 - TipRanks
Clarivate Completes Refinancing of Majority of Senior Secured No - GuruFocus
Clarivate Completes Refinancing of Majority of Senior Secured Notes Due 2026 – Company Announcement - Financial Times
Clarivate (CLVT) Expands Partnership with CAPES to Broaden Brazi - GuruFocus
Clarivate (CLVT) Expands Partnership with CAPES to Broaden Brazilian Access | CLVT Stock News - GuruFocus
Clarivate and CAPES Expand Landmark Partnership to Power Researc - GuruFocus
Clarivate's Landmark Deal Brings Premium Research Tools to 400+ Brazilian Universities, Boosting National Innovation - Stock Titan
Clarivate’s SWOT analysis: stock faces challenges amid turnaround efforts - Investing.com
Clarivate Unveils AI-Powered Tool for Trademark Risk Assessment - MSN
Clarivate Announces Partial Redemption of Senior Notes - TipRanks
Clarivate Says Unit Issues Notice For $500 Million Partial Redemption Of Outstanding 4.50% Senior Secured Notes Due 2026SEC Filing - marketscreener.com
Clarivate Launches AI-based RiskMark to Accelerate Trademark Con - GuruFocus
Clarivate Launches AI-based RiskMark to Accelerate Trademark Conflict Assessments - aapnews.aap.com.au
Clarivate Launches AI-Based RiskMark To Accelerate Trademark Conflict Assessments - Barchart.com
Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market - The Globe and Mail
Clarivate to stop counting citations to retracted articles in journals’ impact factors - Retraction Watch
Clarivate Report Reveals Top Trademark Portfolios | CLVT Stock N - GuruFocus
Clarivate Report Reveals Top Trademark Portfolios | CLVT Stock News - GuruFocus
Clarivate Report Reveals Top Trademark Portfolios - marketscreener.com
New Global Trademark Report Reveals How 7 Major Brands Dominate International IP Portfolios - Stock Titan
Clarivate Enhances OFF-X with Pathway Maps to Accelerate Target Safety Assessments | CLVT Stock News - GuruFocus
Drug Development Breakthrough: Clarivate Tackles 30% Safety Failure Rate with New Visual Safety Assessment Tool - Stock Titan
Clarivate Shareholders Approve Key Proposals at AGM - TipRanks
Clarivate Shareholders Approve All Proposals at 2025 AGM - Investing.com
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report - The Globe and Mail
Optimistic Investors Push Clarivate Plc (NYSE:CLVT) Shares Up 27% But Growth Is Lacking - simplywall.st
Clarivate outlines 2025 strategy with focus on subscription growth and AI-driven innovation - MSN
Clarivate: Organic Growth Has Reached A Potential Inflection Point - Seeking Alpha
Clarivate Plc (NYSE:CLVT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - Yahoo Finance
Clarivate (CLVT) Receives a Hold from RBC Capital - The Globe and Mail
Why Clarivate Plc (CLVT) Soared on Tuesday - MSN
Stifel maintains Buy rating on Clarivate stock with $7 target - Investing.com Australia
Stifel maintains Buy rating on Clarivate stock with $7 target By Investing.com - Investing.com Nigeria
Clarivate Plc Stock (CLVT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clarivate Plc Stock (CLVT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bomba Jane L Okun | Director |
Mar 12 '25 |
Buy |
4.03 |
49,750 |
200,492 |
49,750 |
| Pritchett Wendell E. | Director |
Mar 03 '25 |
Buy |
4.38 |
22,857 |
100,114 |
71,835 |
| SAHA SAURABH | Director |
Mar 03 '25 |
Buy |
4.36 |
58,275 |
254,079 |
82,016 |
| Angelakis Michael J | Director |
Nov 20 '24 |
Buy |
5.11 |
1,500,000 |
7,665,000 |
1,500,000 |
| Angelakis Michael J | Director |
Nov 21 '24 |
Buy |
5.19 |
1,200,000 |
6,228,000 |
2,700,000 |
| Angelakis Michael J | Director |
Nov 22 '24 |
Buy |
5.19 |
765,000 |
3,970,350 |
3,465,000 |
| Veinstein Bar | President, A&G |
Oct 15 '24 |
Sale |
7.00 |
60,000 |
420,000 |
916,583 |
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):